Steven Robert Martin, Senior VP & CFO at APRICUS BIOSCIENCES, INC. (APRI), bought 20,000 shares at $2.85 ($57K) on 2013-05-23, disclosed to the SEC on 2013-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.